Zoetis
ProfileJobs

Zoetis

Suggest Edit
    • Healthbiotechdrug developmentpetspharmaveterinary

    Zoetis, Inc. is the producer of medicine and vaccinations for pets and livestock. The Company has a diversified business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

    Revenue(FY, 2017)
    $5.3 B
    Market capitalization(2018-06-14)
    $42.7 B
    Type
    Public
    HQ
    Parsippany-Troy Hills, US
    Founded
    1952
    Size (employees)
    9,200 (est)+3%
    Website
    zoetis.com
    Zoetis was founded in 1952 and is headquartered in Parsippany-Troy Hills, US
    Report incorrect company information

    Key People/Management at Zoetis

    Juan Alaix

    Juan Alaix

    CEO
    Kristin Peck

    Kristin Peck

    Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
    Heidi Chen

    Heidi Chen

    Executive Vice President and General Counsel
    Glenn David

    Glenn David

    Executive Vice President and Chief Financial Officer
    Andrew Fenton

    Andrew Fenton

    Executive Vice President and Chief Information Officer
    Catherine Knupp

    Catherine Knupp

    Executive Vice President and President, Research and Development
    Show more

    Zoetis Office Locations

    Zoetis has an office in Parsippany-Troy Hills
    Parsippany-Troy Hills, US (HQ)
    10 Sylvan Way
    Show all (1)
    Report incorrect company information

    Zoetis Financials and Metrics

    Zoetis Financials

    Zoetis's revenue was reported to be $5.31 b in FY, 2017
    USD

    Revenue (Q1, 2018)

    		1.4 b

    Gross profit (Q1, 2018)

    		919 m

    Gross profit margin (Q1, 2018), %

    		67.3%

    Market capitalization (14-Jun-2018)

    		42.7 b

    Closing share price (14-Jun-2018)

    		88.2

    Cash (31-Mar-2018)

    		1.7 b
    Zoetis's current market capitalization is $42.7 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		4.6 b4.8 b4.8 b4.9 b5.3 b

    Revenue growth, %

    		5%0%3%

    Cost of goods sold

    		1.7 b1.7 b1.7 b1.8 b

    Gross profit

    		2.9 b3.1 b3.2 b3.5 b
    Quarterly
    USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017Q1, 2018

    Revenue

    		1.2 b1.2 b1.2 b1.2 b1.2 b1.3 b1.2 b1.3 b1.4 b

    Cost of goods sold

    		427 m421 m410 m389 m399 m435 m443 m440 m447 m

    Gross profit

    		748 m793 m831 m773 m809 m912 m788 m829 m919 m

    Gross profit Margin, %

    		64%65%67%67%67%68%64%65%67%
    show all
    Annual
    USDFY, 2016FY, 2017

    Cash

    		727 m1.6 b

    Accounts Receivable

    		34.6 m

    Inventories

    		1.5 b1.4 b

    Current Assets

    		3.4 b4.2 b
    Quarterly
    USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017Q1, 2018

    Cash

    		544 m592 m651 m675 m658 m2 b629 m705 m1.7 b

    Inventories

    		1.4 b1.4 b1.6 b1.5 b1.5 b1.5 b1.5 b1.5 b1.4 b

    Current Assets

    		3.3 b3.5 b3.4 b3.3 b3.3 b4.9 b3.4 b3.6 b4.3 b

    Goodwill

    		1.2 b1.2 b1.5 b1.5 b1.5 b1.5 b1.5 b1.5 b1.5 b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    		819 m

    Depreciation and Amortization

    		60 m60 m85 m

    Inventories

    		(101 m)

    Accounts Payable

    		(28 m)
    Quarterly
    USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q1, 2018

    Net Income

    		350 m

    Depreciation and Amortization

    		15 m15 m21 m21 m22 m22 m60 m

    Inventories

    		1.4 b1.4 b1.6 b1.5 b1.5 b1.5 b(33 m)

    Accounts Payable

    		278 m306 m241 m210 m224 m231 m(46 m)
    show all
    USDY, 2018

    Financial Leverage

    		4.4 x
    Show all financial metrics

    Zoetis Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Abaxis May 15, 2018$1.90 b
    Report incorrect company information

    Competitors

    PetLife Pharmaceuticals
    Health - Public
    Skyline Vet Pharma
    Manufacturing & Industrial - Private
    Vetoquinol
    Health - Public
    Kindred Biosciences
    Health - Public
    Compare competitors

    Zoetis Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Zoetis News and Updates

    May 16, 2018

    Southeast Asia Pet Care Market will Register a CAGR of 6.8% through 2020

    Rise in Per Capita GDP and changing consumer attitude towards pets has brought a considerable shift among people towards pet health and wellness. Posted via Industry Today. Follow us on Twitter @IndustryToday
    May 16, 2018

    Zoetis to buy Abaxis for $1.9 bln in cash

    May 16 (Reuters) - Animal health company Zoetis Inc said on Wednesday it would buy Abaxis Inc, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.
    May 04, 2018

    Market Research on Veterinary Respiratory Disease Treatment Market 2016 and Analysis to 2026

    Future Market Insights has announced the addition of the “Veterinary Respiratory Disease Treatment Market: Global Industry Analysis and Opportunity Assessment, 2016-2026"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
    May 02, 2018

    Zoetis (ZTS) Q1 2018 Results - Earnings Call Transcript

    May 02, 2018

    Zoetis 2018 Q1 - Results - Earnings Call Slides

    March 29, 2018

    Buy Align Technology And Zoetis - Cramer's Lightning Round (3/28/18)

    Show more
    Report incorrect company information
    Download PDF